Fresh Rounds

Akava Therapeutics Inc. funding

Akava Therapeutics Inc., a pharmaceuticals company based in Winnetka, IL, filed a Form D with the SEC on February 19, 2026 and reported a $15M offering with no sales yet.

Amount raisedNot yet sold
Offering size$15M
Filed with the SECFebruary 19, 2026
First saleYet to occur
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationWinnetka, IL
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far0
Minimum investment$100K
Revenue rangeDecline to Disclose

Other health care rounds in Illinois